These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9289681)

  • 1. [Data on cholesterol level screening of patients with ischemic heart disease in the light of the Scandinavian Simvastatin Survival Study].
    Márk L; Kondacs A; Hanyecz V; Simondán G
    Orv Hetil; 1997 Jun; 138(26):1679-82. PubMed ID: 9289681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.
    Johannesson M; Jönsson B; Kjekshus J; Olsson AG; Pedersen TR; Wedel H
    N Engl J Med; 1997 Jan; 336(5):332-6. PubMed ID: 9011785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
    Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
    Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin].
    Gavelli MS; Vitaliano E; Serra T; Rossi FG; Rizzuti A; Caridis R; Tozzi J
    Clin Ter; 1990 May; 133(3):145-50. PubMed ID: 2142901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F; Brown AS; Reiber I; Adams PC
    Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercholesterolemia in the aged: rational approach to the problem].
    Antonicelli R; Lipponi G; Cadeddu G; Gaetti R
    Clin Ter; 1990 Aug 15-31; 134(3-4):173-80. PubMed ID: 2147617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scandinavian simvastatin study (4S).
    Grodos D; Tonglet R
    Lancet; 1994 Dec 24-31; 344(8939-8940):1768. PubMed ID: 7997017
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Scandinavian Simvastatin Survival Study].
    Faergeman O; Haghfelt T
    Ugeskr Laeger; 1995 Jan; 157(4):458-60. PubMed ID: 7846795
    [No Abstract]   [Full Text] [Related]  

  • 15. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lowering LDL cholesterol with Simvastatin. Also, economically reasonable!].
    Internist (Berl); 1995 Aug; 36(8 Suppl):1-4. PubMed ID: 9131077
    [No Abstract]   [Full Text] [Related]  

  • 17. Which statin is most efficient for the treatment of hypercholesterolemia? A cost-effectiveness analysis.
    Cobos A; Jovell AJ; García-Altés A; García-Closas R; Serra-Majem L
    Clin Ther; 1999 Nov; 21(11):1924-36. PubMed ID: 10890264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment with statins: further data from the Heart Protection Study].
    Tonstad S; Holme I
    Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2777-80. PubMed ID: 12523144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of medicamentous cholesterol control on resources utilization in public health--significance of the Scandinavian Simvastatin Survival Study (4-S Study) for cost control in Swiss health management conditions].
    Szucs TD; Lüscher TF; Gutzwiller F
    Schweiz Med Wochenschr; 1997 Nov; 127(44):1819-23. PubMed ID: 9446200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.